Results 121 to 130 of about 16,159 (251)
Tetrabenazine for the Treatment of Tardive Dyskinesia
, 2011 Objective: To evaluate the safety and effectiveness of tetrabenazine for the treatment of tardive dyskinesia. Data Sources: Literature was accessed through MEDLINE (1966-September 2010) and The Cochrane Library using the terms tetrabenazine, tardive ...
Jonathan G Leung, Ericka L Breden
core +1 more source
Exercise and Motor Complications in Parkinson's Disease: A Systematic Review and Meta‐Analysis
Movement Disorders Clinical Practice, EarlyView.Abstract Background Levodopa remains the most effective pharmacological treatment for Parkinson's disease (PD), but long‐term use commonly leads to motor complications such as levodopa‐induced dyskinesia (LID) and motor fluctuations, significantly contributing to disability. Exercise is well‐established for improving motor and non‐motor symptoms in PD;
Priscila Nóbrega‐Sousa +5 more
wiley +1 more source
Methylphenidate, Neuroleptics and Dyskinesia-Dystonia
, 1980 Methlyphenidate is one of two stimulant drugs used in the management of the Hyperkinetic Reaction in children. It has been known to have side effects such as dyskinesia, but this case details the emergence of dystonia and dyskinesia when the ...
James Chapel +2 more
core +1 more source
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.Abstract Background Continuous subcutaneous foslevodopa/foscarbidopa (LDp/CDp) provides 24‐h delivery of levodopa‐carbidopa prodrugs for advanced Parkinson's disease. Real‐world 1‐year European data remain limited. Objectives To characterize 1‐year changes in motor, non‐motor, autonomic, quality‐of‐life and sleep outcomes, and in concomitant therapy ...
Mario Hero +5 more
wiley +1 more source
Dyskinesia Induced By Phenytoin.
, 2015 Phenytoin is an effective antiepileptic drug, although, it can be associated with many side effects, including dyskinesia. To describe the clinical characteristics of phenytoin induced dyskinesia.
Scotoni, A E, Montenegro, M A, Cendes, F
core
Effect of bilateral subthalamic deep brain stimulation on diphasic dyskinesia
, 2008 OBJECTIVES: The goal of this study was to assess the effect of bilateral subthalamic deep brain stimulation (STN DBS) on levodopa-induced diphasic dyskinesia in patients with Parkinson disease (PD).
Lee, Jee-Young +5 more
core +1 more source
An intriguing case of abdominal pain—Belly dancer's syndrome
Clinical Case ReportsKey Clinical Message Belly dancer dyskinesia, a rare disease, may often be overlooked as a regular nonspecific abdominal pain, and therefore, high index of clinical suspicion is required to avert misdiagnosis.
Dhriti Sundar Das
doaj +1 more source
, 1996 Geç diskinezi nöroleptik ilaçlarla sağaltımın göreceli olarak geç döneminde ortaya çıkan bir hareket bozukluğudur. Uzun süre nöroleptik sağaltım alan hastaların yaklaşık %15-20’sinde görüldüğü, ileri yaş, kadın cinsiyet, duygudurum bozukluğu tanısının ...
M. Ayşın Noyan
core
Paliperidone ER-induced Tardive Dyskinesia
, 2013 The evidence suggests a lower tardive dyskinesia risk associated with atypical antipsychotics. We present two adult female cases with tardive dyskinesia. Tardive perioral dyskinesia developed in patients at the ninth and twelfth months of paliperidone ER
YANARTAŞ, ÖMER
core +1 more source
A Gap Analysis of Deep Brain Stimulation for Childhood‐Onset Movement Disorders
Movement Disorders, EarlyView.Abstract Background Deep brain stimulation (DBS) is an established and increasingly utilized therapy for childhood‐onset movement disorders. However, pediatric DBS poses unique challenges that are not adequately addressed by adult‐derived paradigms. Objective To identify key gaps in the current use of DBS in childhood‐onset movement disorders and to ...
Daniela Munoz‐Chesta +6 more
wiley +1 more source